US20130081953A1 - Method for treating the surface of a device for dispensing a fluid product - Google Patents

Method for treating the surface of a device for dispensing a fluid product Download PDF

Info

Publication number
US20130081953A1
US20130081953A1 US13/514,152 US201013514152A US2013081953A1 US 20130081953 A1 US20130081953 A1 US 20130081953A1 US 201013514152 A US201013514152 A US 201013514152A US 2013081953 A1 US2013081953 A1 US 2013081953A1
Authority
US
United States
Prior art keywords
thin film
support surface
fluid
chemical
acrylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/514,152
Inventor
Pascal Bruna
Matthieu Laurent
Fabien Nekelson
Sébastien Roussel
Lorraine Tessier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aptar France SAS
Original Assignee
Valois SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valois SAS filed Critical Valois SAS
Assigned to APTAR FRANCE SAS reassignment APTAR FRANCE SAS CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: VALOIS
Assigned to VALOIS SAS reassignment VALOIS SAS ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BRUNA, PASCAL, LAURENT, MATTHIEU, NEKELSON, FABIEN, ROUSSEL, SEBASTIEN, TESSIER, LORRAINE
Publication of US20130081953A1 publication Critical patent/US20130081953A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D7/00Electroplating characterised by the article coated
    • C25D7/04Tubes; Rings; Hollow bodies
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/12Chemical modification
    • C08J7/16Chemical modification with polymerisable compounds
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D3/00Electroplating: Baths therefor
    • C25D3/02Electroplating: Baths therefor from solutions
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D5/00Electroplating characterised by the process; Pretreatment or after-treatment of workpieces
    • C25D5/02Electroplating of selected surface areas
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D5/00Electroplating characterised by the process; Pretreatment or after-treatment of workpieces
    • C25D5/54Electroplating of non-metallic surfaces
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D9/00Electrolytic coating other than with metals
    • C25D9/02Electrolytic coating other than with metals with organic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • A61M15/0068Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/007Mechanical counters
    • A61M15/0071Mechanical counters having a display or indicator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/02General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0222Materials for reducing friction
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05BSPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/02Membranes or pistons acting on the contents inside the container, e.g. follower pistons
    • B05B11/028Pistons separating the content remaining in the container from the atmospheric air to compensate underpressure inside the container
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00Processes for applying liquids or other fluent materials
    • B05D1/18Processes for applying liquids or other fluent materials performed by dipping
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D2201/00Polymeric substrate or laminate
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D5/00Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures
    • B05D5/08Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/14Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
    • B65D83/60Contents and propellant separated
    • B65D83/64Contents and propellant separated by piston

Abstract

A treatment method for treating the surface of a fluid dispenser device, said method comprising the step of using chemical grafting to form a thin film on at least one support surface of at least one movable portion of said device that is movable while said device is being actuated, said thin film having anti-friction properties.

Description

  • The present invention relates to a surface treatment method for fluid dispenser devices.
  • Fluid dispenser devices are well known. They generally comprise: one or more reservoirs; a dispenser member, such as a pump, a valve, or a piston that moves in the reservoir; and a dispenser head that is provided with a dispenser orifice. In some configurations, laterally-actuated systems are provided for actuating the dispenser member. Alternatively, in a variant, the fluid dispenser devices may be inhalers including a plurality of reservoirs each containing an individual dose of powder or liquid, and means for opening and expelling said doses during successive actuations. The various devices may also include a dose counter or indicator for counting or indicating the number of doses that have been dispensed or that remain to be dispensed from the dispenser device. Thus, the devices include numerous movable parts or portions that move relative to one another during actuation. Controlling friction, which may cause unwanted noise and/or malfunctions, is a major challenge. In particular in the pharmaceutical field, any risk of the dispenser device malfunctioning may be critical, e.g. for treating attacks such as asthma attacks. In particular, the problem of friction may occur at the pump piston or at the valve member, where it is essential to avoid the pump piston or valve member jamming. The same applies for inhalers, in which the means for moving or opening a reservoir, and the means for dispensing a dose are sensitive to friction, or even for dose counters that must give the user an accurate indication, so that the user is not mistaken about the number of doses remaining to be dispensed. Thus, any blockage as a result of friction is potentially prejudicial.
  • All existing surface treatment methods present drawbacks. Thus, certain methods are suitable for use only on plane surfaces. Other methods impose a limited choice of substrate, e.g. gold. Polymerizing molecules by plasma is complex and costly, and the coating layer obtained is difficult to control and presents problems of aging. Likewise, polymerizing molecules by ultraviolet radiation is also complex and costly, and functions only with photosensitive molecules. The same applies for atom transfer radical polymerization (ATRP) that is also complex and costly. Finally, electrografting methods are complex and require support surfaces that are conductive.
  • An object of the present invention is to propose a surface treatment method that does not have the above-mentioned drawbacks.
  • In particular, an object of the present invention is to provide a surface treatment method that is effective, long-lasting, non-polluting, and simple to perform.
  • The present invention thus provides a treatment method for treating the surface of a fluid dispenser device, said method comprising the step of using chemical grafting to form a thin film on at least one support surface of at least one movable portion of said device that is movable while said device is being actuated, said thin film having anti-friction properties.
  • In an advantageous implementation, said grafting step comprises putting said surface that is in contact with the fluid into contact with a solution that includes at least one adhesive primer, said adhesive primer being a cleavable aryl salt, and at least one monomer or polymer selected from the group constituted by vinyl- or acrylic-terminated siloxanes.
  • Advantageously, said thin film is a polymeric film that includes silicone.
  • Advantageously, said silicone is a DM300 or DM1000 silicone.
  • Advantageously, said chemical grafting creates covalent bonds between the molecules of said thin film and said support surface. This creates a strong and long-lasting connection.
  • Advantageously, said chemical grafting is performed in an aqueous medium. This makes it possible to use chemistry that is non-polluting or green and that does not present any risk to the environment.
  • In an implementation, the cleavable aryl salt is selected from the group constituted by: aryl diazonium salts; aryl ammonium salts; aryl phosphonium salts; aryl sulfonium salts; and aryl iodonium salts.
  • The cleavable aryl salts are selected from compounds of general formula ArN2 +, X in which Ar represents the aryl group and X represents an anion. The aryl group in an organic compound is a functional group derived from an aromatic ring.
  • In an implementation, X anions are selected from: inorganic anions such as halides, such as I—, Cl—, and Br—; halogenoborates such as tetrafluoroborate; and organic anions such as alcoholates, carboxylates, perchlorates, and sulfonates.
  • In an implementation, the aryl groups Ar are selected from possibly mono- or poly-substituted aromatic or heteroaromatic groups constituted by one or more aromatic rings of 3 to 8 carbons. The heteroatoms of the heteroaromatic compounds are selected from N, O, P, and S. The substituents may contain alkyl groups and one or more heteroatoms such as N, O, F, Cl, P, Si, Br, or S.
  • In an implementation, the aryl groups are selected from: aryl groups substituted by attractor groups such as NO2; COH; CN; CO2H; ketones; esters; amines; and halogens.
  • In an implementation, the aryl groups are selected from the group constituted by: phenyl and nitrophenyl groups.
  • In an implementation, the cleavable aryl salt is selected from the group constituted by: phenyldiazonium tetrafluoroborate; 4-nitrophenyldiazonium tetrafluoroborate; 4-bromophenyldiazonium tetrafluoroborate; 4-aminophenyldiazonium chloride; 4-aminomethylphenyldiazonium chloride; 2-methyl-4-chlorophenyldiazonium chloride; 4-benzoylbenzenediazonium tetrafluoroborate; 4-cyanophenyldiazonium tetrafluoroborate; 4-carboxyphenyldiazonium tetrafluoroborate; 4-acetamidophenyldiazonium tetrafluoroborate; 4-phenylacetic acid diazonium tetrafluoroborate; 2-methyl-4-[(2-methylphenyl)diazenyl]benzenediazonium sulfate; 9,10-dioxo-9,10-dihydro-1-anthracenediazonium chloride; 4-nitronaphtalenediazonium tetrafluoroborate; and naphtalenediazonium tetrafluoroborate.
  • In an implementation, the cleavable aryl salt is selected from the group constituted by: 4-nitrophenyldiazonium tetrafluoroborate; 4-aminophenyldiazonium chloride; 2-methyl-4-chlorophenyldiazonium chloride; and 4-carboxyphenyldiazonium tetrafluoroborate.
  • In an implementation, the cleavable aryl salt concentration lies in the range 5×10−3 molar (M) to 10−1 M.
  • In an implementation, the cleavable aryl salt concentration is about 5×10−2 M.
  • In an implementation, the cleavable aryl salt is prepared in situ.
  • Advantageously, said chemical-grafting step is initiated by chemically activating a diazonium salt so as to form an anchor layer for said thin film.
  • Advantageously, said chemical-grafting step is initiated by chemical activation.
  • In an implementation, said chemical activation is initiated by the presence of a reducing agent in the solution.
  • In an implementation, the solution comprises a reducing agent.
  • The term “reducing agent” means a compound that donates electrons during a redox reaction. In an aspect of the present invention, the reducing agent presents a redox potential difference relative to the redox potential of the cleavable aryl salt, that lies in the range 0.3 volts (V) to 3 V.
  • In an aspect of the invention, the reducing agent is selected from the group constituted by: reducing metals that are possibly finely divided, such as iron, zinc, or nickel; a metal salt that is possibly in the form of a metallocene; and an organic reducing agent such as hypophosphorus acid, or ascorbic acid.
  • In an implementation, the reducing agent concentration lies in the range 0.005 M to 2 M.
  • In an implementation, the reducing agent concentration is about 0.6 M.
  • In an implementation, said thin film has a thickness that is less than 1 micrometer (μm), and that lies in the range 10 angstroms (Å) to 2000 Å, advantageously lies in the range 10 Å to 800 Å, preferably lies in the range 400 Å to 1000 Å. No conventional coating technique makes it possible to obtain chemically-grafted layers that are as thin.
  • The term “vinyl- or acrylic-terminated siloxane” means a saturated silicon and oxygen hydride that is formed with straight or branched chains of alternating silicon and oxygen atoms and including terminating vinyl or acrylic motifs.
  • In an implementation, vinyl- or acrylic-terminated siloxanes are selected from the group constituted by: vinyl- or acrylic-terminated polyalkylsiloxanes such as vinyl- or acrylic-terminated polymethylsiloxane; vinyl- or acrylic-terminated polydimethylsiloxane such as polydimethylsiloxane-acrylate (PDMS-acrylate); vinyl- or acrylic-terminated polyarylsiloxanes such as vinyl- or acrylic-terminated polyphenylsiloxane such as polyvinylphenylsiloxane; and vinyl- or acrylic-terminated polyarylalkylsiloxanes such as vinyl- or acrylic-terminated polymethylphenylsiloxane.
  • In an implementation, a potential difference is applied in said solution.
  • The term “potential difference” means the redox potential difference measured between two electrodes.
  • In an implementation, the potential difference is applied by a generator that is connected to two electrodes that are identical or different and that are dipped in the solution during the dipping step.
  • In an implementation, the electrodes are selected from: stainless steel; steel; nickel; platinum; gold; silver; zinc; iron; and copper; in pure form or in alloy form.
  • In an implementation, the electrodes are made of stainless steel.
  • In an implementation, the potential difference applied by a generator lies in the range 0.1 V to 2 V.
  • In an implementation, it is about 0.7 V.
  • In an implementation, the potential difference is generated by a chemical cell.
  • The term “chemical cell” means a cell that is made up of two electrodes that are interconnected via an ionic bridge. In the present invention, the two electrodes are selected appropriately for the potential difference to lie in the range 0.1 V to 2.5 V.
  • In an implementation, the chemical cell is created between two different electrodes that are dipped in the solution.
  • In an implementation, the electrodes are selected from: nickel; zinc; iron; copper; and silver; in pure form or in alloy form.
  • In an implementation, the potential difference generated by the chemical cell lies in the range 0.1 V to 1.5 V.
  • In an implementation, the potential difference is about 0.7 V.
  • In an implementation, the electrodes are chemically isolated so as to avoid any contact between the substrate that is immersed in the solution and the electrodes that are also dipped in the solution.
  • Advantageously, said support surface is made of: synthetic material, in particular comprising polyethylene (PE) and/or polypropylene (PP); elastomer; glass; or metal.
  • Advantageously, the method further comprises the step of using chemical grafting to form at least one additional thin film on said support surface.
  • Advantageously, the method further comprises the step of using chemical grafting to form a first additional thin film on said support surface, said first additional thin film limiting the degree to which the fluid for dispensing sticks to said support surface.
  • Advantageously, the method further comprises the step of using chemical grafting to form a second additional thin film on said support surface, said second additional thin film preventing interactions between said support surface and said fluid.
  • In a variant, said at least one additional thin film is deposited on said support surface during at least one successive chemical-grafting step, each step being performed in a single-component bath.
  • In another variant, said at least one additional thin film is deposited on said support surface simultaneously during a single chemical-grafting step in a multi-component bath.
  • Advantageously, said dispenser device comprises: a reservoir containing the fluid; a dispenser member, such as a pump or a valve, that is fastened on said reservoir; and a dispenser head that is provided with a dispenser orifice, and this is for actuating said dispenser member.
  • In a variant, said dispenser device comprises: a plurality of individual reservoirs each containing a dose of fluid; reservoir opening means, such as a perforator needle; and dose dispenser means for dispensing a dose of fluid from an individual opened reservoir through a dispenser orifice.
  • In a variant, said dispenser device includes a reservoir containing one or two doses of fluid, and a piston that moves in said reservoir on each actuation.
  • Advantageously, said dispenser device includes a dose counter for counting the number of doses that have been dispensed or that remain to be dispensed from said dispenser device.
  • Advantageously, said fluid is a pharmaceutical, in particular for spraying in nasal or oral manner.
  • In an implementation, it is possible to use a method similar to the method described in document WO 2008/078052, which describes a method of preparing an organic film on the surface of a solid support under non-electrochemical conditions. Surprisingly, that type of method turns out to be suitable for forming a thin anti-friction film on surfaces that are movable during the actuation of the above-mentioned dispenser devices. Such an application of that grafting method has not previously been envisaged.
  • To summarize, the method seeks to prepare a thin film, in particular a film made of polyethylene and/or polypropylene, on the surface of a solid support. The method mainly comprises putting said support surface into contact with a liquid solution. The liquid solution includes at least one solvent and at least one adhesive primer, enabling radical entities to be formed from the adhesive primer.
  • The “thin film” may be any polymeric film, in particular of organic nature, e.g. resulting from a plurality of units of organic chemical species, and bonded in covalent manner to the surface of the support on which the method is performed. In particular, it is a film that is bonded in covalent manner to the surface of the support, and that includes at least one layer of structural units of similar nature. Depending on the thickness of the film, its cohesion is provided by covalent bonds that develop between the various units. Preferably, the thin film contains silicone.
  • The solvent used in the context of the method may be of protic or aprotic nature. It is preferable for the primer to be soluble in said solvent.
  • The term “protic solvent” means a solvent that includes at least one hydrogen atom that is capable of being released in the form of a proton. The protic solvent may be selected from the group constituted by: water; deionized water; optionally-acidified distilled water; acetic acid; hydroxylated solvents such as methanol and ethanol; liquid glycols of small molecular weight such as ethyleneglycol; and mixtures thereof. In a first variant, the protic solvent is constituted solely by a protic solvent or by a mixture of different protic solvents. In another variant, the protic solvent or the mixture of protic solvents may be mixed with at least one aprotic solvent, it being understood that the resulting mixture should present the characteristics of a protic solvent. Acidified water is the preferred protic solvent, and more particularly, acidified distilled water or acidified deionized water.
  • The term “aprotic solvent” means a solvent that is considered as not being protic. Under non-extreme conditions, such solvents are not suitable for releasing a proton or for accepting one. The aprotic solvent is advantageously selected from: dimethylformamide (DMF); acetone; and dimethyl sulfoxide (DMSO).
  • The term “adhesive primer” corresponds to any organic molecule that is suitable, under certain conditions, for chemisorbing onto the support surface by a radical reaction, such as radical chemical grafting. Such molecules include at least a functional group that is suitable for reacting with a radical, and also a reactive function that reacts with another radical after chemiabsorption. Thus, after grafting a first molecule to the surface of the support, the molecules are capable of forming a polymeric film, and then of reacting with other molecules that are present in its environment.
  • The term “radical chemical grafting” refers, in particular, to the use of molecular entities that possess an unpaired electron in order to form bonds with the support surface of the covalent-bond type, said molecular entities being generated independently of the support surface onto which they are to be grafted. Thus, the radical reaction leads to covalent bonds being formed between the support surface under consideration and the derivative of the grafted adhesive primer, and then between a grafted derivative and molecules that are present in its environment.
  • The term “derivative of the adhesive primer” means a chemical unit resulting from the adhesive primer, after said adhesive primer has reacted by radical chemical grafting, in particular with the support surface, or with another radical. To the person skilled in the art, it is clear that the function that is reactive with another radical after chemiabsorption of the derivative of the adhesive primer is different from the function involved in the covalent bonding, in particular with the support surface. Advantageously, the adhesive primer is a cleavable aryl salt selected from the group constituted by: aryl diazonium salts; aryl ammonium salts; aryl phosphonium salts; aryl sulfonium salts; and aryl iodonium salts.
  • Preferably, the thin film includes silicone that may be of various medical grades, e.g. DM300 or DM1000. As a variant to the direct covalent bonds of the silicone on the support surface, as obtained in an aqueous medium, it is also possible to use a method of impregnating a porous layer that has previously been grafted with silicone.
  • In an advantageous implementation of the invention, chemical grafting is used to form at least one additional thin film on a single support surface, so as to give at least one other property to the support surface. Thus, the fluid for dispensing may tend to stick to a surface with which it is in contact, and this may, in particular, have a harmful effect on the reproducibility of the dispensed dose. The invention advantageously makes provision for using chemical grafting to form a first additional thin film that prevents the fluid from sticking to the support surface. Advantageously, it is also possible to envisage using chemical grafting to apply a second additional thin film, so as to give a third property to the support surface. For example, in fluid dispenser devices, certain materials interact with the fluid for dispensing in the event of coming into contact therewith, and this may be harmful to the fluid. The invention advantageously makes provision for using chemical grafting to form a second additional thin film that prevents interaction between the fluid and the support surface. The additional thin films may be applied during successive chemical-grafting steps. Each chemical-grafting step may then be performed in a single-component bath. It should be observed that the successive chemical-grafting steps may be performed in any order. In a variant, the additional thin films may alternatively be applied during a single chemical-grafting step that is thus performed in a multi-component bath. A combination of the two variants may also be envisaged.
  • The present invention applies to multidose devices, such as devices having a pump or a valve mounted on a reservoir, and that are actuated so as to dispense successive doses. It also applies to multidose devices that include a plurality of individual reservoirs, each containing a dose of fluid, such as pre-dosed powder inhalers. It also applies to uni-dose or bi-dose devices in which a piston moves directly in a reservoir on each actuation. In particular, the invention applies to nasal or oral spray devices, to opthalmic dispenser devices, and to needle devices of the syringe type.
  • The invention also relates to the use of a grafting method of the invention in order to form a thin film on at least one support surface of at least one movable portion of a fluid dispenser device that is movable while said device is being actuated, said thin film having anti-friction properties.
  • The following examples were performed in a glass vessel. Unless indicated to the contrary, they were performed under normal temperature and pressure conditions (about 22° C. under about 1 atmosphere (atm)) in ambient air. Unless mentioned to the contrary, the reagents used were obtained directly on the market without additional purification. The samples were subjected beforehand to washing under ultrasound in soapy water at 40° C.
  • EXAMPLE 1 Grafting a Poly(Dimethylsiloxane) Film onto Parts of a Pump so as to Lubricate it
  • The term “pump” means a fluid dispenser device that is actuated manually, and that includes a pump body in which one or more pistons slide.
  • Vinyl-terminated poly(dimethylsiloxane) (1.0 gram (g), 5 grams per liter (g/L)) was poured into a solution of Brij® 35 (0.874 g at 4.37 g/L) in 70 milliliters (mL) of milliQ (mQ) water, then the suspension was stirred magnetically so as to form an emulsion.
  • 4-aminobenzoic acid (1.370 g, 10−2 moles (mol)) was dissolved in a solution of hydrochloric acid (4.0 mL in 120 mL of mQ water) and of hypophosphorus acid (6.3 mL, 6.0×10−2 mol). That solution was added to the PDMS emulsion.
  • To that emulsion there were added 8 mL of an aqueous solution of NaNO2 (0.667 g, 9.7×10−3 mol), and then the pump-part samples.
  • After 30 minutes of reaction, the samples, namely: a body made of PP; an upper piston; a lower piston; and a tube made of polyethylene PE; were removed, then rinsed in successive baths of soapy water (Renoclean) at 1% under ultrasound at 40° C., and baths of water.
  • After drying the parts with compressed air, the presence of PDMS on the samples was confirmed by infrared (IR) analysis by means of PDMS-specific bands at 1260 per centimeter (cm−1), 1110 cm−1, and 1045 cm−1.
  • EXAMPLE 2 Grafting a Poly(Dimethylsiloxane) Film onto Parts of a Valve so as to Lubricate it
  • The term “valve” means a fluid dispenser device that contains propellant gases, and that includes a valve body in which a valve member slides.
  • Sodium dodecyl benzene sulfonate (1.307 g, 0.015 M) was dissolved in 175 mL of mQ water. Vinyl-terminated poly(dimethylsiloxane) (2.5 g, 10 g/L) was added, then the mixture was stirred magnetically so as to form an emulsion.
  • 4-aminobenzoic acid (3.462 g, 2.5×10−2 mol) was dissolved in a solution of hydrochloric acid (9.6 mL in 20 mL of mQ water) and of hypophosphorus acid (33 mL, 3.1×10−1 mol). That solution was added to the PDMS emulsion.
  • To that emulsion there were added 10 mL of a solution of NaNO2 (1.664 g, 2.37×10−2 mol) in mQ water, and then the samples, namely: ethylene propylene diene monomer (EPDM) or nitrile rubber gaskets; a valve member top made of polyoxymethylene (POM); and a gold indicator strip.
  • After 15 minutes of reaction, the samples were removed, then rinsed successively in mQ water, in ethanol, and in hexane.
  • The presence of PDMS on the gold strip and on the other samples was confirmed by IR analysis with PDMS-specific bands at 1260 cm−1, 1110 cm−1, and 1045 cm−1.
  • EXAMPLE 3 Electrocatalyzed Chemical Grafting of a Polymer Film Made of Acrylic-PDMS onto a Polyethylene Substrate
  • This example explains how to graft a lubricating coating (acrylic-PDMS) onto a thermoplastic such as PE.
  • The PE samples were washed in ethanol, under ultrasound (at 50% power, temperature at 40° C.) for 5 minutes.
  • The biphasic solution was prepared in two stages. The following were added to a beaker (1), in order and under magnetic stirring (at 300 revolutions per minute (rpm)): PDMS-acrylate (1 g/L); Brij® 35 in solution in water at 8.5% by weight (% wt) (4.37 g/L); and 33 mL of deionized (DI) water. Emulsification then took place under ultrasound at 40° C. and at a power of 200 watts (W) (100%) for 15 minutes.
  • The following were added to a beaker (2), under magnetic stirring (at 300 rpm): nitrobenzene diazonium tetrafluoroborate (0.05 mol/L); 130 mL of DI water; and hydrochloric acid (0.23 mol/L).
  • The content of beaker (2) was poured into the emulsion of beaker (1). The PE samples (×2); a winding of galvanized steel wire (ten turns, i.e. a length of about 25 centimeters (cm) to 30 cm); and a winding of nickel (Ni) wire (ten turns, i.e. a length of about 25 cm to 30 cm); were placed in beaker (1). The two wires were connected together and an ammeter was connected in series.
  • Finally, once the assembly was ready, hypophosphorus acid (0.7 mol/L) was added last, thereby marking the start of the reaction. After 30 minutes of reaction at ambient temperature, the PE samples were removed, then rinsed successively in water, in ethanol, and finally in isopropanol, in a soxhlet extractor for 16 hours.
  • The soxhlet was composed of: a glass body in which the sample was placed; a siphon-tube; and a distillation tube. The soxhlet was placed on a flask (specifically a 500 mL flask heated and stirred via a flask heater) containing the solvent (specifically 300 mL of isopropanol) and surmounted by a condenser.
  • When the flask was heated, the solvent vapor passed via the distillation tube, condensed in the condenser, and dropped back into the glass body, thereby soaking the sample in pure solvent (heated by the underlying vapor). The condensed solvent accumulated in the extractor until it reached the top of the siphon-tube which then caused the liquid to return to the vessel, accompanied by extracted substances, and the solvent contained in the vessel was thus enriched progressively with soluble compounds.
  • The solvent thus continued to evaporate, while the extracted substances remained in the vessel (their boiling temperature needs to be significantly higher than the boiling temperature of the extractor solvent).
  • The use of a soxhlet extractor made it possible to confirm the chemical grafting of acrylic-PDMS on the surface of the PE substrate.
  • An analysis by IR spectroscopy was performed. The infrared spectrum made it possible to confirm the grafting of acrylic-PDMS by the presence of the characteristic band at 1260 cm−1 corresponding to the vibration of the Si—CH3 bond.
  • EXAMPLE 4 Electrocatalyzed Chemical Grafting of a Polymer Film Made of Acrylic-PDMS onto a Polyethylene Substrate in the Presence of a Potentiostat
  • This example explains how to graft a lubricating coating (acrylic-PDMS) onto a thermoplastic such as PE in the presence of a potentiostat.
  • The PE samples were washed in ethanol, under ultrasound (power at 100 W, temperature at 40° C.) for 5 minutes.
  • The biphasic solution was prepared in two stages. The following were added to a beaker (1), in order and under magnetic stirring (at 300 rpm): PDMS-acrylate (1 g/L); Brij® 35 in solution in water at 8.5% wt (4.37 g/L); and 33 mL of DI water. Emulsification then took place under ultrasound at 40° C. and at a power of 200 W (100%) for 15 minutes.
  • The following were added to a beaker (2), under magnetic stirring (at 300 rpm): nitrobenzene diazonium tetrafluoroborate (0.05 mol/L); 130 mL of DI water; and hydrochloric acid (0.23 mol/L).
  • The content of beaker (2) was poured into the emulsion of beaker (1). The PE samples (×2); a winding of galvanized steel wire (ten turns, i.e. a length of about 25 cm to 30 cm); and a winding of Ni wire (ten turns, i.e. a length of about 25 cm to 30 cm); were placed in beaker (1). The two wires were connected to a potentiostat and an ammeter was connected in series. The potentiostat imposed a constant potential difference of 0.5 V and the current over time was measured by the ammeter.
  • Finally, once the assembly was ready, hypophosphorus acid (0.7 mol/L) was added last, thereby marking the start of the reaction. After 30 minutes of reaction at ambient temperature, the PE samples were removed, then rinsed successively in water (a cascade), then in ethanol (a cascade), and finally in isopropanol, in a soxhlet extractor for 16 hours.
  • The use of a soxhlet extractor made it possible to confirm the chemical grafting of acrylic-PDMS on the surface of the PE substrate.
  • An analysis by IR spectroscopy was performed. The IR spectrum made it possible to confirm the grafting of acrylic-PDMS by the presence of the characteristic band at 1260 cm−1 corresponding to the vibration of the Si—CH3 bond.
  • Various modifications may also be envisaged by a person skilled in the art, without going beyond the ambit of the present invention, as defined by the accompanying claims.

Claims (23)

1. A treatment method for treating the surface of a fluid dispenser device, said method being characterized in that it comprises a step of using chemical grafting to form a thin film on at least one support surface of at least one movable portion of said device that is movable while said device is being actuated, said thin film having anti-friction properties.
2. A method according to claim 1, wherein said grafting step comprises putting said surface that is in contact with the fluid into contact with a solution that includes at least one adhesive primer, said adhesive primer being a cleavable aryl salt, and at least one monomer or polymer selected from the group constituted by vinyl- or acrylic-terminated siloxanes.
3. A method according to claim 1, wherein vinyl- or acrylic-terminated siloxanes are selected from the group constituted by: vinyl- or acrylic-terminated polyalkylsiloxanes such as vinyl- or acrylic-terminated polymethylsiloxane; vinyl- or acrylic-terminated polydimethylsiloxane such as polydimethylsiloxane-acrylate (PDMS-acrylate); vinyl- or acrylic-terminated polyarylsiloxanes such as vinyl- or acrylic-terminated polyphenylsiloxane such as polyvinylphenylsiloxane; and vinyl- or acrylic-terminated polyarylalkylsiloxanes such as vinyl- or acrylic-terminated polymethylphenylsiloxane.
4. A method according to claim 1, wherein the cleavable aryl salt is selected from the group constituted by: aryl diazonium salts; aryl ammonium salts; aryl phosphonium salts; aryl sulfonium salts; and aryl iodonium salts.
5. A method according to claim 1, wherein said chemical-grafting step is initiated by chemical activation.
6. A method according to claim 5, wherein said chemical activation is initiated by the presence of a reducing agent in the solution.
7. A method according to claim 6, wherein the reducing agent is selected from the group constituted by: reducing metals that are possibly finely divided, such as iron, zinc, or nickel; a metal salt that is possibly in the form of a metallocene; and an organic reducing agent such as hypophosphorus acid, or ascorbic acid.
8. A method according to claim 1, wherein a potential difference is applied in said solution.
9. A method according to claim 8, wherein the potential difference is applied by a generator that is connected to two electrodes that are identical or different and that are dipped in the solution.
10. A method according to claim 8, wherein the potential difference is generated by a chemical cell.
11. A method according to claim 1, wherein said support surface is made of: synthetic material, in particular comprising polyethylene and/or polypropylene; elastomer; glass; or metal.
12. A method according to claim 1, wherein said thin film has a thickness that is less than 1 μm, preferably lying in the range 10 Å to 2000 Å.
13. A method according to claim 1, wherein the method further comprises the step of using chemical grafting to form at least one additional thin film on said support surface.
14. A method according to claim 13, wherein the method further comprises the step of using chemical grafting to form a first additional thin film on said support surface, said first additional thin film limiting the degree to which the fluid for dispensing sticks to said support surface.
15. A method according to claim 13, wherein the method further comprises the step of using chemical grafting to form a second additional thin film on said support surface, said second additional thin film preventing interactions between said support surface and said fluid.
16. A method according to claim 13, wherein said at least one additional thin film is deposited on said support surface during at least one successive chemical-grafting step, each step being performed in a single-component bath.
17. A method according to claim 13, wherein said at least one additional thin film is deposited on said support surface simultaneously during a single chemical-grafting step in a multi-component bath.
18. A method according to claim 1, wherein said dispenser device comprises: a reservoir containing the fluid; a dispenser member, such as a pump or a valve, that is fastened on said reservoir; and a dispenser head that is provided with a dispenser orifice, and this is for actuating said dispenser member.
19. A method according to claim 1, wherein said dispenser device comprises: a plurality of individual reservoirs each containing a dose of fluid; reservoir opening means, such as a perforator needle; and dose dispenser means for dispensing a dose of fluid from an individual opened reservoir through a dispenser orifice.
20. A method according to claim 1, wherein said dispenser device includes a reservoir containing one or two doses of fluid, and a piston that moves in said reservoir on each actuation.
21. A method according to claim 1, wherein said dispenser device includes a dose counter for counting the number of doses that have been dispensed or that remain to be dispensed from said dispenser device.
22. A method according to claim 1, wherein said fluid is a liquid or powder pharmaceutical, in particular for spraying in nasal or oral manner.
23. The use of a grafting method according to claim 1, in order to form a thin film on at least one support surface of at least one movable portion of a fluid dispenser device that is movable while said device is being actuated, said thin film having anti-friction properties.
US13/514,152 2009-12-23 2010-12-22 Method for treating the surface of a device for dispensing a fluid product Abandoned US20130081953A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0959479 2009-12-23
FR0959479A FR2954326B1 (en) 2009-12-23 2009-12-23 METHOD FOR SURFACE TREATMENT OF A FLUID PRODUCT DISPENSING DEVICE
PCT/FR2010/052888 WO2011077055A1 (en) 2009-12-23 2010-12-22 Method for treating the surface of a device for dispensing a fluid product

Publications (1)

Publication Number Publication Date
US20130081953A1 true US20130081953A1 (en) 2013-04-04

Family

ID=42312784

Family Applications (1)

Application Number Title Priority Date Filing Date
US13/514,152 Abandoned US20130081953A1 (en) 2009-12-23 2010-12-22 Method for treating the surface of a device for dispensing a fluid product

Country Status (6)

Country Link
US (1) US20130081953A1 (en)
EP (1) EP2516524A1 (en)
JP (1) JP2013515805A (en)
CN (1) CN102639616A (en)
FR (1) FR2954326B1 (en)
WO (1) WO2011077055A1 (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834954B2 (en) 2009-05-13 2014-09-16 Sio2 Medical Products, Inc. Vessel inspection apparatus and methods
US9272095B2 (en) 2011-04-01 2016-03-01 Sio2 Medical Products, Inc. Vessels, contact surfaces, and coating and inspection apparatus and methods
US9458536B2 (en) 2009-07-02 2016-10-04 Sio2 Medical Products, Inc. PECVD coating methods for capped syringes, cartridges and other articles
US9474869B2 (en) 2011-02-28 2016-10-25 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone
US9545360B2 (en) 2009-05-13 2017-01-17 Sio2 Medical Products, Inc. Saccharide protective coating for pharmaceutical package
US9554968B2 (en) 2013-03-11 2017-01-31 Sio2 Medical Products, Inc. Trilayer coated pharmaceutical packaging
US9664626B2 (en) 2012-11-01 2017-05-30 Sio2 Medical Products, Inc. Coating inspection method
US9662450B2 (en) 2013-03-01 2017-05-30 Sio2 Medical Products, Inc. Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus
US9764093B2 (en) 2012-11-30 2017-09-19 Sio2 Medical Products, Inc. Controlling the uniformity of PECVD deposition
US9814838B2 (en) 2011-01-26 2017-11-14 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US9863042B2 (en) 2013-03-15 2018-01-09 Sio2 Medical Products, Inc. PECVD lubricity vessel coating, coating process and apparatus providing different power levels in two phases
US9878101B2 (en) 2010-11-12 2018-01-30 Sio2 Medical Products, Inc. Cyclic olefin polymer vessels and vessel coating methods
US9903782B2 (en) 2012-11-16 2018-02-27 Sio2 Medical Products, Inc. Method and apparatus for detecting rapid barrier coating integrity characteristics
US9937099B2 (en) 2013-03-11 2018-04-10 Sio2 Medical Products, Inc. Trilayer coated pharmaceutical packaging with low oxygen transmission rate
US10189603B2 (en) 2011-11-11 2019-01-29 Sio2 Medical Products, Inc. Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus
US10201660B2 (en) 2012-11-30 2019-02-12 Sio2 Medical Products, Inc. Controlling the uniformity of PECVD deposition on medical syringes, cartridges, and the like
US11066745B2 (en) 2014-03-28 2021-07-20 Sio2 Medical Products, Inc. Antistatic coatings for plastic vessels
US11077233B2 (en) 2015-08-18 2021-08-03 Sio2 Medical Products, Inc. Pharmaceutical and other packaging with low oxygen transmission rate
US11116695B2 (en) 2011-11-11 2021-09-14 Sio2 Medical Products, Inc. Blood sample collection tube
US11617716B2 (en) 2021-06-10 2023-04-04 Belhaven BioPharma Inc. Dry powder formulations of epinephrine and associated methods
US11624115B2 (en) 2010-05-12 2023-04-11 Sio2 Medical Products, Inc. Syringe with PECVD lubrication

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3003482B1 (en) 2013-03-19 2016-06-24 Aptar France Sas METHOD FOR SURFACE TREATMENT OF A DOSING VALVE

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050255631A1 (en) * 2002-08-26 2005-11-17 Commissariat A L'energie Atomique Method of soldering a polymer surface to a conducting or semiconducting surface and applications of same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980231A (en) * 1988-02-19 1990-12-25 Snyder Laboratories, Inc. Process for coating polymer surfaces and coated products produced using such process
EP0872512B1 (en) * 1997-04-14 2001-05-09 Degussa AG Process for modifying the surface of polymeric substrates by graft polymerisation
EP1208864B2 (en) * 1998-02-23 2012-06-06 Glaxo Group Limited Improvements in drug delivery devices
GB9814717D0 (en) * 1998-02-23 1998-09-02 Bespak Plc Improvements in drug delivery devices
US6358557B1 (en) * 1999-09-10 2002-03-19 Sts Biopolymers, Inc. Graft polymerization of substrate surfaces
SE0004610D0 (en) * 2000-12-13 2000-12-13 Astrazeneca Ab Surface modification process
FR2821575B1 (en) * 2001-03-02 2003-10-24 Commissariat Energie Atomique METHOD OF LOCALIZED ORGANIC GRAFTING WITHOUT MASK ON CONDUCTIVE OR SEMICONDUCTOR PROPERTIES OF COMPOSITE SURFACES
AUPS041002A0 (en) * 2002-02-08 2002-03-07 Commonwealth Scientific And Industrial Research Organisation Synthetic closure
US8043632B2 (en) * 2003-08-18 2011-10-25 E. I. Du Pont De Nemours And Company Process for making antimicrobial articles by reacting chitosan with amino-reactive polymer surfaces
CN101091947A (en) * 2006-06-20 2007-12-26 中国科学院兰州化学物理研究所 Method for preparing ultra hydrophobic surface on surface of metal copper
FR2910010B1 (en) 2006-12-19 2009-03-06 Commissariat Energie Atomique PROCESS FOR PREPARING AN ORGANIC FILM ON THE SURFACE OF A SOLID SUPPORT UNDER NON-ELECTROCHEMICAL CONDITIONS, SOLID CARRIER THUS OBTAINED AND PREPARATION KIT
FR2943930B1 (en) * 2009-04-02 2011-09-30 Commissariat Energie Atomique METHOD FOR MODIFYING THE SURFACE ENERGY OF A SOLID

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050255631A1 (en) * 2002-08-26 2005-11-17 Commissariat A L'energie Atomique Method of soldering a polymer surface to a conducting or semiconducting surface and applications of same

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834954B2 (en) 2009-05-13 2014-09-16 Sio2 Medical Products, Inc. Vessel inspection apparatus and methods
US9572526B2 (en) 2009-05-13 2017-02-21 Sio2 Medical Products, Inc. Apparatus and method for transporting a vessel to and from a PECVD processing station
US10537273B2 (en) 2009-05-13 2020-01-21 Sio2 Medical Products, Inc. Syringe with PECVD lubricity layer
US9545360B2 (en) 2009-05-13 2017-01-17 Sio2 Medical Products, Inc. Saccharide protective coating for pharmaceutical package
US10390744B2 (en) 2009-05-13 2019-08-27 Sio2 Medical Products, Inc. Syringe with PECVD lubricity layer, apparatus and method for transporting a vessel to and from a PECVD processing station, and double wall plastic vessel
US9458536B2 (en) 2009-07-02 2016-10-04 Sio2 Medical Products, Inc. PECVD coating methods for capped syringes, cartridges and other articles
US11624115B2 (en) 2010-05-12 2023-04-11 Sio2 Medical Products, Inc. Syringe with PECVD lubrication
US11123491B2 (en) 2010-11-12 2021-09-21 Sio2 Medical Products, Inc. Cyclic olefin polymer vessels and vessel coating methods
US9878101B2 (en) 2010-11-12 2018-01-30 Sio2 Medical Products, Inc. Cyclic olefin polymer vessels and vessel coating methods
US9814838B2 (en) 2011-01-26 2017-11-14 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US10322239B2 (en) 2011-01-26 2019-06-18 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US9474869B2 (en) 2011-02-28 2016-10-25 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US10143792B2 (en) 2011-02-28 2018-12-04 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US9272095B2 (en) 2011-04-01 2016-03-01 Sio2 Medical Products, Inc. Vessels, contact surfaces, and coating and inspection apparatus and methods
US11724860B2 (en) 2011-11-11 2023-08-15 Sio2 Medical Products, Inc. Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus
US11116695B2 (en) 2011-11-11 2021-09-14 Sio2 Medical Products, Inc. Blood sample collection tube
US10189603B2 (en) 2011-11-11 2019-01-29 Sio2 Medical Products, Inc. Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus
US10577154B2 (en) 2011-11-11 2020-03-03 Sio2 Medical Products, Inc. Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus
US11148856B2 (en) 2011-11-11 2021-10-19 Sio2 Medical Products, Inc. Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus
US11884446B2 (en) 2011-11-11 2024-01-30 Sio2 Medical Products, Inc. Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus
US9664626B2 (en) 2012-11-01 2017-05-30 Sio2 Medical Products, Inc. Coating inspection method
US9903782B2 (en) 2012-11-16 2018-02-27 Sio2 Medical Products, Inc. Method and apparatus for detecting rapid barrier coating integrity characteristics
US9764093B2 (en) 2012-11-30 2017-09-19 Sio2 Medical Products, Inc. Controlling the uniformity of PECVD deposition
US10363370B2 (en) 2012-11-30 2019-07-30 Sio2 Medical Products, Inc. Controlling the uniformity of PECVD deposition
US11406765B2 (en) 2012-11-30 2022-08-09 Sio2 Medical Products, Inc. Controlling the uniformity of PECVD deposition
US10201660B2 (en) 2012-11-30 2019-02-12 Sio2 Medical Products, Inc. Controlling the uniformity of PECVD deposition on medical syringes, cartridges, and the like
US9662450B2 (en) 2013-03-01 2017-05-30 Sio2 Medical Products, Inc. Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus
US10912714B2 (en) 2013-03-11 2021-02-09 Sio2 Medical Products, Inc. PECVD coated pharmaceutical packaging
US11344473B2 (en) 2013-03-11 2022-05-31 SiO2Medical Products, Inc. Coated packaging
US9554968B2 (en) 2013-03-11 2017-01-31 Sio2 Medical Products, Inc. Trilayer coated pharmaceutical packaging
US10016338B2 (en) 2013-03-11 2018-07-10 Sio2 Medical Products, Inc. Trilayer coated pharmaceutical packaging
US9937099B2 (en) 2013-03-11 2018-04-10 Sio2 Medical Products, Inc. Trilayer coated pharmaceutical packaging with low oxygen transmission rate
US11684546B2 (en) 2013-03-11 2023-06-27 Sio2 Medical Products, Inc. PECVD coated pharmaceutical packaging
US11298293B2 (en) 2013-03-11 2022-04-12 Sio2 Medical Products, Inc. PECVD coated pharmaceutical packaging
US10537494B2 (en) 2013-03-11 2020-01-21 Sio2 Medical Products, Inc. Trilayer coated blood collection tube with low oxygen transmission rate
US9863042B2 (en) 2013-03-15 2018-01-09 Sio2 Medical Products, Inc. PECVD lubricity vessel coating, coating process and apparatus providing different power levels in two phases
US11066745B2 (en) 2014-03-28 2021-07-20 Sio2 Medical Products, Inc. Antistatic coatings for plastic vessels
US10220158B2 (en) 2014-07-18 2019-03-05 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone
US11077233B2 (en) 2015-08-18 2021-08-03 Sio2 Medical Products, Inc. Pharmaceutical and other packaging with low oxygen transmission rate
US11617716B2 (en) 2021-06-10 2023-04-04 Belhaven BioPharma Inc. Dry powder formulations of epinephrine and associated methods
US11872308B2 (en) 2021-06-10 2024-01-16 Belhaven BioPharma Inc. Dry powder formulations of epinephrine and associated methods

Also Published As

Publication number Publication date
FR2954326A1 (en) 2011-06-24
JP2013515805A (en) 2013-05-09
FR2954326B1 (en) 2013-01-18
EP2516524A1 (en) 2012-10-31
CN102639616A (en) 2012-08-15
WO2011077055A1 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
US20130081953A1 (en) Method for treating the surface of a device for dispensing a fluid product
Chinwangso et al. Multidentate adsorbates for self-assembled monolayer films
Li et al. Molecular layer deposition of thiol− ene multilayers on semiconductor surfaces
US10800931B2 (en) Conductive polymeric coatings, medical devices, coating solutions and methods
Watson et al. A “clickable” titanium surface platform
US20130022750A1 (en) Method for treating the surface of a device for dispensing a fluid product
CN114730663A (en) Corrosion-resistant permanent magnet for intravascular blood pump
JPWO2019131872A1 (en) A substrate for forming a polymer brush, a method for producing the substrate, and a precursor liquid used in the method.
Quinones et al. Polystyrene formation on monolayer-modified nitinol effectively controls corrosion
Rengifo et al. “Click-functional” block copolymers provide precise surface functionality via spin coating
US20120318677A1 (en) Method for treating the surface of a device for dispensing a fluid product
US20120225185A1 (en) Method for treating the surface of a device for dispensing a fluid product
US10485938B2 (en) Process for the surface treatment of a metering valve
US20110056854A1 (en) Method For Preparing A Lubricating Film, Solid Support Thus Obtained And Preparation Kit
EP2622023A1 (en) Methods of preparing a metal nanoparticle-containing silicone composition
US9505029B2 (en) Modification of substrate surfaces with polymer coatings
US9534309B2 (en) Coating method by electrocatalyzed chemical grafting of a surface of a substrate with a polymeric layer
KR101026513B1 (en) A Modified Solid Substrate Using Hydroxybenzene-Amine and a Method of modifying the Surface of a Solid Substrate Using the Same
Mesnage Diazonium salts induced anchoring process: mechanism, application (s)
Fedel et al. Innovative Silanes-Based Pretreatment to Improve the Adhesion of Organic Coatings
US20130005913A1 (en) Method for treating the elastomer surface of a device for dispensing a fluid product

Legal Events

Date Code Title Description
AS Assignment

Owner name: APTAR FRANCE SAS, FRANCE

Free format text: CHANGE OF NAME;ASSIGNOR:VALOIS;REEL/FRAME:028930/0956

Effective date: 20120725

AS Assignment

Owner name: VALOIS SAS, FRANCE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BRUNA, PASCAL;NEKELSON, FABIEN;TESSIER, LORRAINE;AND OTHERS;REEL/FRAME:029502/0910

Effective date: 20120308

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION